Topic Archives: Denali Therapeutics (DNLI)

Every year we call out a “turkey” stock teaser around Thanksgiving time and poke a bit of fun at some terrible investment ideas… … so it seems only fair to highlight a few winners as well, and this week, when we’re getting ready to close down for the holiday, seems a good time to spread […]

I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

Here’s the lead-in to the ad that caught our readers’ attention this week: “This ‘Perfect Storm’ Stock Is Set to Deliver Big Pharma a Swift and Devastating DEATHBLOW It Won’t Come Back From… “And Launch This Little Company on A 72-Hour, $8.98 Billion All-Out SPRINT” And there’s a deadline… today, in fact, when there will […]

Ray Blanco makes (part of) his living looking for biotech moonshots, like most biotech-focused newsletter writers — and like his predecessor at Agora’s biotech and emerging tech-focused newsletter Breakthrough Technology Alert, he has often touted companies that are trying to end the scourge of Alzheimer’s Disease. Why? Well, two main reasons: First, and by far […]

Comments

  • Likely still DNLI (https://www.stockgumshoe.com/reviews/behind-the-markets/is-the-end-of-alzheimers-going-to-be-jeff-bez...

  • Michael, based upon your assessment, it appears that you feel an investment in DNLI is considerably premature. Regards, ...

  • You just have to look at The Gates foundation to see evidence of billionaires wasting billions without return and in som...

  • You are right, all the clues do point to DNLI. But all the pieces for them to have it altogether in the Alzheimer field...

  • NTRP has just completed Phase 2 trials and seem to be very successful with their drug Bryo>>>> which is adm...

  • Believe NTRP is closer to Alzheimer cure with their Phase 2 trials just ready to be announced. Have invested in a small...

  • NTRP is more likely to make an Alzheimer's-related move this year than DNLI, I expect, though don't, of course, know if ...

  • Read Ray Blanco's Alzheimer's pitch also. Wasn't going to pay thousands for any newsletter.! Researched myself and ...

  • Researched after viewing Ray Blanco...think a promising company is NTRP just finished Phase 2 with FDA trials and will a...

  • Blanco is at it again. https://pro.sevenfiguresolutions.com/p/VPI_moneybrainv4_0719/EVPIV842/?a=13&o=138585&s=162274&u...

  • What is Blanco's latest. Is it DNLI?...

  • I wonder what the correlation is between the pumps and fund rasing by the companies. Naturally these types of companie...

  • i spent two hours sleuthing -- DNLI and ESALY were the only 2 public cos i found. KH MD...

  • Wish I'd known about you before I invested in DNLI. I bought the tease, as I am totally new to investing in stocks. I ...

  • Thank you Travis. You have confirmed my own research and conclusion on Blanco's "tiny" company as DNLI and done so with ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info